Non-stimulant meds include atomoxetine, guanfacine ER, clonidine ER, and viloxazine ER, used when stimulants don’t suit you.
If you’ve tried stimulants and felt wired, crashed hard, lost your appetite, or couldn’t sleep, you’re not stuck. There are prescription options for attention symptoms that aren’t stimulants. They work differently, tend to feel smoother through the day, and can be a better match when anxiety, tics, blood pressure issues, or sleep trouble is part of the picture.
This article walks through the main non-stimulant medication choices used for ADD/ADHD, what they’re like day to day, and how to weigh trade-offs with your prescriber. It isn’t a substitute for personal medical care. It’s a way to show up to that visit with clearer questions and fewer surprises.
Why Some People Prefer Non-stimulant ADHD Medication
Stimulants can work fast for many people. Still, speed isn’t the only thing that counts. People often pick non-stimulants for reasons that show up in real life:
- They want steadier coverage. A smoother day can beat a strong morning followed by an afternoon crash.
- Sleep is already shaky. A medicine that doesn’t rev up the body can be easier on bedtime.
- Appetite is a struggle. Some people can’t afford another appetite drop.
- Tics or irritability flare. Some non-stimulants feel gentler for certain people.
- There’s a misuse concern. A non-stimulant can lower stress for patients and families.
Non-stimulants can also be paired with a stimulant. That combo is common when a stimulant helps focus but evenings are rough, or when impulsivity is still loud even with better attention.
Non-stimulant Options FDA Cleared For ADHD
In the United States, four non-stimulant medicines are FDA-cleared for ADHD symptoms: atomoxetine (Strattera), guanfacine extended-release (Intuniv), clonidine extended-release (Kapvay), and viloxazine extended-release (Qelbree). The FDA’s consumer overview lists these as the non-stimulant set. FDA overview of ADHD treatment options
Clinicians also use other medicines off-label in certain situations. Off-label choices need extra care and close follow-up, so this article stays with the FDA-cleared set to keep the facts easy to verify.
Atomoxetine
Atomoxetine isn’t a stimulant and it isn’t a controlled substance in the U.S. It’s often described as a norepinephrine reuptake inhibitor. In plain terms, it can help the brain hold onto a signal tied to attention and self-control. It tends to build over time rather than hitting all at once.
Many people notice less mental “drift” and better follow-through. Side effects can include nausea, stomach upset, appetite change, dizziness, or sleepiness in some people. MedlinePlus profile for atomoxetine
Guanfacine ER
Guanfacine ER is an alpha-2A adrenergic agonist. The day-to-day effect often shows up as fewer snap reactions, better impulse control, and calmer task switching. Some people also notice less physical restlessness.
Drowsiness, low blood pressure, and dry mouth can happen, especially early on or after a dose bump. Many clinicians move dose steps slowly so daytime life stays workable.
Clonidine ER
Clonidine ER is also an alpha-agonist. It’s often used when hyperactivity is the loudest symptom, and it can be handy when sleep onset is part of the struggle since it may be more sedating than guanfacine for some people.
Because it can lower blood pressure and heart rate, prescribers often check vitals and ask about faintness or unusual fatigue. It also shouldn’t be stopped suddenly without guidance, since rebound blood pressure spikes can occur.
Viloxazine ER
Viloxazine ER is a newer option in the U.S. market under the brand Qelbree. Its prescribing information carries a boxed warning about suicidal thoughts and behaviors, a point prescribers take seriously during early treatment and dose changes. Qelbree (viloxazine ER) prescribing information
Some people report a “clearer head” feel rather than a push. Response varies a lot person to person, so tracking sleep, appetite, and mood helps you and your clinician judge fit.
How Non-stimulants Tend To Feel Day To Day
Non-stimulants often feel like the volume on distractions is turned down, not like a sudden surge of drive. You may still need a plan for your day. The plan just sticks better because your brain doesn’t slide off it as easily.
A common theme is fewer “peaks and valleys.” Once the dose is right, many people feel more even across the day, with less of a “wear-off” moment.
One catch: patience matters. These options often take days to weeks to show their full effect. That delay is not failure. It’s part of the mechanism.
ADD Medications That Are Not Stimulants Compared Side By Side
Below is a broad comparison. Dosing ranges vary by age, weight, and product, so treat this as a discussion tool, not a dosing chart.
| Option | When It’s Often Picked | Watch-outs To Plan For |
|---|---|---|
| Atomoxetine | Need all-day coverage; stimulant intolerance; misuse concern | Stomach upset early on; appetite change; mood monitoring in youth |
| Guanfacine ER | Impulsivity, hyperactivity, reactivity, tics | Sleepiness; low blood pressure; slow dose steps |
| Clonidine ER | Hyperactivity plus sleep-onset trouble; evening restlessness | More sedation; vitals checks; don’t stop abruptly |
| Viloxazine ER | Need a non-stimulant trial; prior stimulant side effects | Mood shifts to watch; sleepiness or insomnia; appetite changes |
| Alpha-agonist + stimulant | Stimulant helps focus, but late-day behavior is rough | Vitals monitoring; timing to avoid daytime grogginess |
| Atomoxetine + stimulant | Partial response to stimulant alone | Side effects can stack; needs close follow-up |
| Switching class | One group didn’t fit after a fair trial | Allow time for washout or a cross-taper plan |
| Medication + routine changes | Need structure help alongside symptom relief | Meds don’t replace routines; plan small and repeatable |
Picking The Right Non-stimulant Fit
There isn’t a single “best” option. The best fit is the one that improves daily function with side effects you can live with. Prescribers usually weigh age, other diagnoses, current meds, blood pressure, sleep pattern, and what your day looks like.
When attention drift is the main issue
If you can sit still but your mind slides off the work, atomoxetine or viloxazine may land on the shortlist. They’re often tried when the aim is steadier cognitive control across the whole day.
When impulsivity and reactivity drive the trouble
Guanfacine ER and clonidine ER often come up when the hardest part is pausing before acting, handling frustration, or dialing down physical restlessness.
When sleep is fragile
Timing matters as much as the medicine. Some people do well taking a sedating option in the evening. Others get the opposite effect. That’s why a simple sleep log during the first few weeks can be useful.
When blood pressure or heart rate run low
Alpha-agonists can lower blood pressure and heart rate, so clinicians may choose another option or start with very small dose steps. If you already get lightheaded when you stand, mention it early.
When mood symptoms are in the mix
This is where close follow-up matters. Atomoxetine and viloxazine labels include warnings about suicidal thinking in children and adolescents. Clinicians may ask about mood, irritability, and any self-harm thoughts at baseline and during dose changes. Strattera (atomoxetine) prescribing information
What A Fair Trial Looks Like
A “fair trial” means enough time at a reasonable dose to judge effect, with side effects handled as well as possible. Many “failed” trials are rushed trials.
Pick a target you can measure
Choose one or two outcomes you can count: fewer missed deadlines, fewer arguments during transitions, finishing a reading assignment without three restarts, or getting to bed within a set window.
Change one variable at a time
If you adjust the medication dose, keep caffeine steady for a week. If you overhaul your sleep schedule, keep the dose steady. Clear signals beat guesses.
Give it room to build
Non-stimulants often ramp up. Some days you’ll think nothing is happening, then you notice you finished a work block without drifting. That’s the change you’re chasing.
Side Effects And Practical Ways To Handle Them
Side effects are real, yet many are manageable with timing, food, hydration, and slower dose steps. The goal is a net gain in function with a body that still feels like yours.
| Side effect | What people try | When to call the prescriber |
|---|---|---|
| Sleepiness | Shift dose later; ask about slower titration | Severe daytime nodding off; fainting |
| Insomnia | Move dose earlier; cut late caffeine; fixed bedtime | Several nights with little sleep; agitation |
| Nausea or stomach upset | Take with food; steady hydration | Persistent vomiting; pain that won’t settle |
| Low blood pressure symptoms | Rise slowly; drink water; slow dose steps | Fainting; chest pain |
| Dry mouth | Sip water; sugar-free gum | Mouth sores; trouble swallowing |
| Appetite change | Plan breakfast; set meal reminders; track weight weekly | Fast weight loss; nutrition slipping |
| Mood shift | Track irritability daily; protect sleep | Self-harm thoughts; sudden aggression |
Switching From A Stimulant To A Non-stimulant
If you’re switching, the plan depends on side effects, current dose, and how stable you need to be at work or school. Some people stop one and start the other the next day. Others cross-taper. Your clinician will pick what fits your case.
These two steps help many people avoid chaos during a switch:
- Pick a quieter window. Avoid big exams, travel weeks, or major deadlines if you can.
- Write down the main reason for the switch. Sleep, appetite, mood, blood pressure, crash, or short coverage. Stick to that goal.
Questions To Bring To Your Prescriber
Bring these to the visit and circle the three that matter most to you. A focused visit leads to clearer decisions.
- Which symptom are we trying to change first: distractibility, impulsivity, restlessness, sleep, or mood?
- How long should I stay at each dose before we judge it?
- What side effect would make you want me to call right away?
- What time of day should I take it for my schedule?
- Do we need blood pressure or heart rate checks at home?
- If this one doesn’t fit, what’s our next option?
Non-stimulant options can be a strong match for the right person. The trick is not guessing. It’s tracking real-life change, staying consistent long enough to judge, and adjusting with your clinician until the benefit is clear.
References & Sources
- U.S. Food and Drug Administration (FDA).“Treating and Dealing with ADHD.”Lists FDA-cleared stimulant and non-stimulant options and outlines treatment basics.
- MedlinePlus (NIH).“Atomoxetine: MedlinePlus Drug Information.”Summarizes uses, common side effects, and safety warnings for atomoxetine.
- FDA Prescribing Information.“Strattera (atomoxetine) Label.”Provides boxed warning and detailed safety information for atomoxetine.
- FDA Prescribing Information.“Qelbree (viloxazine ER) Label.”Provides boxed warning and detailed safety information for viloxazine ER.